Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Chrysanthemyl diphosphate synthase: isolation of the gene and characterization of the recombinant non-head-to-tail monoterpene synthase from Chrysanthemum cinerariaefolium.

Rivera SB, Swedlund BD, King GJ, Bell RN, Hussey CE Jr, Shattuck-Eidens DM, Wrobel WM, Peiser GD, Poulter CD.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4373-8. Epub 2001 Apr 3.

2.

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A, et al.

JAMA. 1997 Oct 15;278(15):1242-50.

PMID:
9333265
3.

Genetic susceptibility to breast and ovarian cancer.

Skolnick MH, Frank T, Shattuck-Eidens D, Tavtigian S.

Pathol Biol (Paris). 1997 Mar;45(3):245-9. Review.

PMID:
9296070
4.

BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, Olsen R, Neuhausen S, Shattuck-Eidens D, Conte PF, Skolnick MH, Bevilacqua G.

Oncogene. 1996 Oct 3;13(7):1483-8.

PMID:
8875986
5.

Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA, Simard J.

J Med Genet. 1996 Oct;33(10):814-9.

6.

Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

Durocher F, Shattuck-Eidens D, McClure M, Labrie F, Skolnick MH, Goldgar DE, Simard J.

Hum Mol Genet. 1996 Jun;5(6):835-42.

PMID:
8776600
7.

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.

Nat Genet. 1996 May;13(1):126-8.

PMID:
8673092
8.

BRCA2 germline mutations in male breast cancer cases and breast cancer families.

Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL.

Nat Genet. 1996 May;13(1):123-5.

PMID:
8673091
9.

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE.

Nat Genet. 1996 Mar;12(3):333-7.

PMID:
8589730
10.

Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1.

Hattier T, Bell R, Shaffer D, Stone S, Phelps RS, Tavtigian SV, Skolnick MH, Shattuck-Eidens D, Kamb A.

Mamm Genome. 1995 Dec;6(12):873-9.

PMID:
8747927
11.

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, et al.

JAMA. 1995 Feb 15;273(7):535-41.

PMID:
7837387
12.

A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1.

Neuhausen SL, Swensen J, Miki Y, Liu Q, Tavtigian S, Shattuck-Eidens D, Kamb A, Hobbs MR, Gingrich J, Shizuya H, et al.

Hum Mol Genet. 1994 Nov;3(11):1919-26.

PMID:
7874107
13.

BRCA1 mutations in primary breast and ovarian carcinomas.

Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al.

Science. 1994 Oct 7;266(5182):120-2.

PMID:
7939630
14.

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.

Science. 1994 Oct 7;266(5182):66-71.

PMID:
7545954
15.

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.

Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, et al.

Nat Genet. 1994 Sep;8(1):23-6.

PMID:
7987388
16.

Rapid detection of maize DNA sequence variation.

Shattuck-Eidens DM, Bell RN, Mitchell JT, McWhorter VC.

Genet Anal Tech Appl. 1991 Dec;8(8):240-5.

PMID:
1817577
17.
20.

Supplemental Content

Loading ...
Support Center